KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to 0.07%.

  • Bristol Myers Squibb's Return on Capital Employed rose 2600.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.07% for FY2025, which is 2500.0% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Return on Capital Employed is 0.07%, which was up 2600.0% from 0.1% recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Capital Employed peaked at 0.02% during Q1 2023, and registered a low of 0.32% during Q4 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Return on Capital Employed value was 0.08% (recorded in 2025), while the average stood at 0.11%.
  • As far as peak fluctuations go, Bristol Myers Squibb's Return on Capital Employed crashed by -2900bps in 2024, and later soared by 2600bps in 2025.
  • Bristol Myers Squibb's Return on Capital Employed (Quarter) stood at 0.02% in 2021, then tumbled by -54bps to 0.03% in 2022, then grew by 1bps to 0.03% in 2023, then tumbled by -915bps to 0.32% in 2024, then soared by 80bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q4 2025, compared to 0.1% in Q3 2025 and 0.11% in Q2 2025.